Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease.

Coluzzi F, Raffa RB, Pergolizzi J, Rocco A, Locarini P, Cenfra N, Cimino G, Mattia C.

J Pain Res. 2015 May 8;8:229-38. doi: 10.2147/JPR.S83490. eCollection 2015.

2.

Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.

Za T, De Stefano V, Rossi E, Petrucci MT, Andriani A, Annino L, Cimino G, Caravita T, Pisani F, Ciminello A, Torelli F, VillivĂ  N, Bongarzoni V, Rago A, Betti S, Levi A, Felici S, Gentilini F, Calabrese E, Leone G; Multiple Myeloma GIMEMA-Latium Region Working Group.

Br J Haematol. 2013 Mar;160(5):673-9. doi: 10.1111/bjh.12168. Epub 2012 Dec 13.

PMID:
23240810
3.

Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.

Rago A, Grammatico S, Za T, Levi A, Mecarocci S, Siniscalchi A, De Rosa L, Felici S, Bongarzoni V, Piccioni AL, La Verde G, Pisani F, Franceschini L, Paviglianiti AL, Caravita T, Petrucci MT, De Stefano V, Cimino G; Multiple Myeloma GIMEMA-Latium Region Working Group.

Cancer. 2012 Nov 15;118(22):5544-9. doi: 10.1002/cncr.27657. Epub 2012 Jul 11.

Supplemental Content

Loading ...
Support Center